1. Studies from Duke University Medical Center Further Understanding of Multiple Myeloma (Phase I Study of Opaganib, an Oral Sphingosine Kinase 2-specific Inhibitor, In Relapsed And/or Refractory Multiple Myeloma).
- Subjects
MULTIPLE myeloma ,SPHINGOSINE kinase ,ACADEMIC medical centers ,BLOOD protein disorders ,KINASE inhibitors ,MELPHALAN - Abstract
Keywords: Durham; State:North Carolina; United States; North and Central America; Alcohols; Amino Alcohols; Blood Protein Disorders; Cancer; Clinical Research; Clinical Trials and Studies; Drugs and Therapies; Enzymes and Coenzymes; Glycols; Health and Medicine; Hematologic Diseases and Conditions; Hematology; Hemic and Lymphatic Diseases and Conditions; Hemorrhagic Disorders; Hemostatic Disorders; Immunoproliferative Disorders; Kinase; Lymphoproliferative Disorders; Multiple Myeloma; Myeloma; Oncology; Paraproteinemias; Pharmaceuticals; Sphingosine; Vascular Diseases and Conditions EN Durham State:North Carolina United States North and Central America Alcohols Amino Alcohols Blood Protein Disorders Cancer Clinical Research Clinical Trials and Studies Drugs and Therapies Enzymes and Coenzymes Glycols Health and Medicine Hematologic Diseases and Conditions Hematology Hemic and Lymphatic Diseases and Conditions Hemorrhagic Disorders Hemostatic Disorders Immunoproliferative Disorders Kinase Lymphoproliferative Disorders Multiple Myeloma Myeloma Oncology Paraproteinemias Pharmaceuticals Sphingosine Vascular Diseases and Conditions 2023 FEB 20 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- Investigators publish new report on Oncology - Multiple Myeloma. Keywords for this news article include: Durham, North Carolina, United States, North and Central America, Alcohols, Amino Alcohols, Blood Protein Disorders, Cancer, Clinical Research, Clinical Trials and Studies, Drugs and Therapies, Enzymes and Coenzymes, Glycols, Health and Medicine, Hematologic Diseases and Conditions, Hematology, Hemic and Lymphatic Diseases and Conditions, Hemorrhagic Disorders, Hemostatic Disorders, Immunoproliferative Disorders, Kinase, Lymphoproliferative Disorders, Multiple Myeloma, Myeloma, Oncology, Paraproteinemias, Pharmaceuticals, Sphingosine, Vascular Diseases and Conditions, Duke University Medical Center. [Extracted from the article]
- Published
- 2023